LSV Asset Management
SCMP

LSV Asset Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

LSV Asset Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-2,471,718
Closed -$44.4M – 1019
2017
Q4 		$44.4M Buy
2,471,718
+5,300
+0.2% +$65.3K 0.07% 265
2017
Q3 		$29.1M Buy
2,466,418
+76,000
+3% +$853K 0.05% 309
2017
Q2 		$25.1M Buy
2,390,418
+44,000
+2% +$449K 0.04% 323
2017
Q1 		$25.8M Buy
2,346,418
+239,200
+11% +$2.78M 0.05% 296
2016
Q4 		$28.6M Buy
2,107,218
+376,302
+22% +$5.25M 0.05% 296
2016
Q3 		$21.3M Buy
1,730,916
+1,248,389
+259% +$14.7M 0.04% 316
2016
Q2 		$5.29M Buy
482,527
+358,127
+288% +$4.01M 0.01% 519
2016
Q1 		$1.36M Buy
+124,400
New +$1.57M ﹤0.01% 709

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

LSV Asset Management's SCMP Position: Q1 2018 in Review

LSV Asset Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 2,471,718 shares — an estimated $44.4M sold.

LSV Asset Management first reported a position in SCMP in Q1 2016 and held it in 8 quarters. The position peaked at $44.4M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • LSV Asset Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • LSV Asset Management sold 2,471,718 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $44.4M.
  • LSV Asset Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2016 and held it in 8 quarters.
  • LSV Asset Management's Sucampo Pharmaceuticals, Inc. position peaked at $44.4M in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on LSV Asset Management's 13F filing for Q1 2018, filed 4 May 2018.